Topical and Conventional Systemic Treatments in Atopic Dermatitis: Have They Gone Out of Fashion?

Overview

Journal Dermatol Pract Concept

Specialty Dermatology

Date 2022 Feb 28

PMID 35223191

Authors

Giulia Calabrese

Gaetano Licata

Alessio Gambardella

Alina DE Rosa

Roberto Alfano

Giuseppe Argenziano

Affiliations

Soon will be listed here.

Abstract

Atopic dermatitis is a Th2 disease, due to relapse of IL-4 and IL-13 by Th2 cells. Despite the approval by FDA of dupilumab, the first monoclonal antibody for the severe forms, traditional drugs remain a milestone for the treatment of this dermatosis. Dermatologists need a good knowledge of all therapies for an integrated and personalized management of patients.

Citing Articles

Efficacy of dupilumab with concomitant topical calcineurin inhibitors treatment for preschool children with atopic dermatitis: a retrospective cohort study.

Liming W, Ali K Ann Med. 2025; 57(1):2449589.

PMID: 39757933 PMC: 11705541. DOI: 10.1080/07853890.2025.2449589.

Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches.

Chaudhary F, Lee W, Escander T, Agrawal D J Biotechnol Biomed. 2024; 7(3):314-328.

PMID: 39119011 PMC: 11309089. DOI: 10.26502/jbb.2642-91280155.

Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches.

Afshari M, Kolackova M, Rosecka M, celakovska J, Krejsek J Front Immunol. 2024; 15:1361005.

PMID: 38500882 PMC: 10944924. DOI: 10.3389/fimmu.2024.1361005.

A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children.

Mohamed A, El Borolossy R, Salah E, Hussein M, Muharram N, Elsalawy N Front Pharmacol. 2023; 14:1202325.

PMID: 37799965 PMC: 10547881. DOI: 10.3389/fphar.2023.1202325.

References

Calabrese G, Gambardella A, Licata G, Di Brizzi E, Alfano R, Argenziano G . Dupilumab and conjunctivitis: a case series of twenty patients. J Eur Acad Dermatol Venereol. 2021; 35(9):e612-e614. DOI: 10.1111/jdv.17210. View

Ribero S, Giura M, Viola R, Ramondetta A, Siliquini N, Cardone P . Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience. J Eur Acad Dermatol Venereol. 2020; 34(8):e380-e383. DOI: 10.1111/jdv.16219. View

Chiricozzi A, Maurelli M, Gori N, Argenziano G, De Simone C, Calabrese G . Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo. J Am Acad Dermatol. 2020; 83(1):39-45. DOI: 10.1016/j.jaad.2020.03.049. View

Furuhashi T, Oda T, Torii K, Nishida E, Morita A . Dupilumab probably reduces transepidermal water loss but does not increase stratum corneum hydration in atopic dermatitis. J Dermatol. 2020; 48(2):e74-e75. PMC: 7891664. DOI: 10.1111/1346-8138.15638. View

Silverberg J, Yosipovitch G, Simpson E, Kim B, Wu J, Eckert L . Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS. J Am Acad Dermatol. 2020; 82(6):1328-1336. DOI: 10.1016/j.jaad.2020.02.060. View

Sidbury R, Davis D, Cohen D, Cordoro K, Berger T, Bergman J . Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014; 71(2):327-49. PMC: 4410179. DOI: 10.1016/j.jaad.2014.03.030. View

Gori N, Chiricozzi A, Malvaso D, DUrso D, Caldarola G, De Simone C . Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy. Dermatology. 2021; 237(4):535-541. DOI: 10.1159/000512890. View

Jaros J, Hendricks A, Shi V, A Lio P . A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis. Dermatitis. 2020; 31(3):169-177. DOI: 10.1097/DER.0000000000000590. View

Draelos Z . An evaluation of prescription device moisturizers. J Cosmet Dermatol. 2009; 8(1):40-3. DOI: 10.1111/j.1473-2165.2009.00422.x. View

10.

Dabade T, Davis D, Wetter D, Hand J, McEvoy M, Pittelkow M . Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic. J Am Acad Dermatol. 2011; 67(1):100-6. DOI: 10.1016/j.jaad.2011.06.025. View

11.

Treister A, Kraff-Cooper C, A Lio P . Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis. JAMA Dermatol. 2018; 154(10):1208-1211. PMC: 6233741. DOI: 10.1001/jamadermatol.2018.2690. View

12.

Blauvelt A, de Bruin-Weller M, Gooderham M, Cather J, Weisman J, Pariser D . Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017; 389(10086):2287-2303. DOI: 10.1016/S0140-6736(17)31191-1. View

13.

Meggitt S, Gray J, Reynolds N . Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet. 2006; 367(9513):839-46. DOI: 10.1016/S0140-6736(06)68340-2. View

14.

Devillers A, Oranje A . Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol. 2006; 154(4):579-85. DOI: 10.1111/j.1365-2133.2006.07157.x. View

15.

Eichenfield L, Tom W, Berger T, Krol A, Paller A, Schwarzenberger K . Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014; 71(1):116-32. PMC: 4326095. DOI: 10.1016/j.jaad.2014.03.023. View

16.

Nolan K, Marmur E . Moisturizers: reality and the skin benefits. Dermatol Ther. 2012; 25(3):229-33. DOI: 10.1111/j.1529-8019.2012.01504.x. View

17.

Rawlings A, Canestrari D, Dobkowski B . Moisturizer technology versus clinical performance. Dermatol Ther. 2004; 17 Suppl 1:49-56. DOI: 10.1111/j.1396-0296.2004.04s1006.x. View